JP2023523413A5 - - Google Patents
Info
- Publication number
- JP2023523413A5 JP2023523413A5 JP2022563869A JP2022563869A JP2023523413A5 JP 2023523413 A5 JP2023523413 A5 JP 2023523413A5 JP 2022563869 A JP2022563869 A JP 2022563869A JP 2022563869 A JP2022563869 A JP 2022563869A JP 2023523413 A5 JP2023523413 A5 JP 2023523413A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- epitope
- coding nucleic
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063013466P | 2020-04-21 | 2020-04-21 | |
| US63/013,466 | 2020-04-21 | ||
| PCT/US2021/028485 WO2021216775A2 (en) | 2020-04-21 | 2021-04-21 | Antigen-encoding cassettes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023523413A JP2023523413A (ja) | 2023-06-05 |
| JP2023523413A5 true JP2023523413A5 (https=) | 2024-05-01 |
Family
ID=78269964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563869A Pending JP2023523413A (ja) | 2020-04-21 | 2021-04-21 | 抗原コードカセット |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230310563A1 (https=) |
| EP (1) | EP4138890A4 (https=) |
| JP (1) | JP2023523413A (https=) |
| KR (1) | KR20230014694A (https=) |
| CN (1) | CN115803049A (https=) |
| AU (1) | AU2021258191A1 (https=) |
| CA (1) | CA3173905A1 (https=) |
| IL (1) | IL296854A (https=) |
| WO (1) | WO2021216775A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3634449A4 (en) | 2017-05-08 | 2021-03-17 | Gritstone Oncology, Inc. | ALPHAVIRUS NEOANTIGEN VECTORS |
| MX2021014525A (es) | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
| CN116438308A (zh) | 2020-08-06 | 2023-07-14 | 磨石生物公司 | 多表位疫苗盒 |
| WO2025028960A1 (ko) * | 2023-07-28 | 2025-02-06 | 주식회사 엘지화학 | 항원 전달용 컨쥬게이트 및 이의 이용 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6514731B1 (en) * | 1996-05-24 | 2003-02-04 | Chiron Corporation | Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens |
| WO2000047229A2 (en) * | 1999-02-11 | 2000-08-17 | Genzyme Corporation | Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules |
| JP2003521245A (ja) * | 1999-12-21 | 2003-07-15 | エピミューン， インコーポレイテッド | ペプチドおよび核酸組成物を使用する、前立腺癌抗原に対する細胞性免疫応答の誘導 |
| SG162817A1 (en) * | 2005-06-17 | 2010-07-29 | Mannkind Corp | Methods and compositions.to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
| CN101721698B (zh) * | 2008-10-24 | 2014-04-02 | 法罗斯疫苗公司 | 抗口蹄疫疫苗组合物及其制备和应用 |
| WO2012114323A1 (en) * | 2011-02-22 | 2012-08-30 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
| WO2017152042A2 (en) * | 2016-03-04 | 2017-09-08 | New York University | Virus vectors expressing multiple epitopes of tumor associated antigens for inducing antitumor immunity |
| AU2019275072A1 (en) * | 2018-05-23 | 2021-01-21 | Seattle Project Corp. | Shared antigens |
| CN110003314B (zh) * | 2019-04-11 | 2023-06-09 | 上海市计划生育科学研究所 | H1n1流感病毒血凝素可诱发广谱保护性抗体的表位肽及其应用 |
-
2021
- 2021-04-21 EP EP21793392.8A patent/EP4138890A4/en active Pending
- 2021-04-21 KR KR1020227040441A patent/KR20230014694A/ko active Pending
- 2021-04-21 CA CA3173905A patent/CA3173905A1/en active Pending
- 2021-04-21 IL IL296854A patent/IL296854A/en unknown
- 2021-04-21 WO PCT/US2021/028485 patent/WO2021216775A2/en not_active Ceased
- 2021-04-21 JP JP2022563869A patent/JP2023523413A/ja active Pending
- 2021-04-21 AU AU2021258191A patent/AU2021258191A1/en active Pending
- 2021-04-21 CN CN202180043892.1A patent/CN115803049A/zh active Pending
-
2022
- 2022-10-20 US US18/048,403 patent/US20230310563A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021525076A5 (https=) | ||
| JP2022512912A5 (https=) | ||
| JP2023526495A5 (https=) | ||
| JP2023523413A5 (https=) | ||
| JP2023541108A5 (https=) | ||
| JP2022539417A5 (https=) | ||
| JP2023523414A5 (https=) | ||
| Gardner et al. | Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein | |
| JP2022534282A5 (https=) | ||
| JP2021524247A5 (https=) | ||
| AU699384B2 (en) | Alphavirus cDNA vectors | |
| Johansson et al. | Intradermal electroporation of naked replicon RNA elicits strong immune responses | |
| JP2023521662A5 (https=) | ||
| Maruggi et al. | Self-amplifying mRNA-based vaccine technology and its mode of action | |
| Anraku et al. | Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity | |
| McAllister et al. | Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases | |
| CN109415416A (zh) | 用于诱导抗肿瘤免疫的表达肿瘤相关抗原的多表位的病毒介体 | |
| JP2023528300A5 (https=) | ||
| AU3427100A (en) | Stable recombinant influenza viruses free of helper viruses | |
| CN117157402A (zh) | 顺式复制子构建体 | |
| JP2023509966A5 (https=) | ||
| FI3652606T3 (fi) | Jaettuihin tuumorineoantigeeneihin perustuva yleisrokote epästabiilien mikrosatelliitti (msi) -syöpien ennaltaehkäisyyn ja hoitoon | |
| CN118086288B (zh) | 多顺反子的自放大rna及制备方法 | |
| JPWO2012053646A1 (ja) | ワクシニアウイルスベクターおよびセンダイウイルスベクターからなるプライム／ブーストワクチン用ウイルスベクター | |
| JP2004501646A5 (https=) |